Oncology

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

Approximately 12.3% of patients diagnosed with heart failure were diagnosed with cancer.

Top news of the week from across the health care landscape.

Research could lead to improved personalized therapies for acute myeloid leukemia.

Selenocompounds were able to kill up to 80% of cancer cells in mice.

Patients treated for high cholesterol showed improved survival in bowel, breast, lung, and prostate cancers.

Analysis of HOX gene able to predict survival in ovarian cancer.

Altered TRPV6 expression is linked to cancer and other diseases.

Participants who lost weight showed decreased expression of proteins that promote tumor-related angiogenesis.

Top news of the day from across the health care landscape.

Compounds found in turmeric and milk thistle inhibit the spread of cancer cells.

A novel technique could resolve current problems with photo-thermal therapy for cancer treatment.

Even low-to-moderate drinking can increase cancer risk.

Liquid biopsy analyzes the urine of patients who underwent digital rectal examinations.

Inferiority ruled for biosimilar of trastuzumab in the treatment of HER2-positive early breast cancer.

Inferiority ruled for biosimilar of trastuzumab in the treatment of HER2-positive early breast cancer.

New approach seeks to overcome chemotherapy resistance in cancer cells.

Colon cancer screenings are largely underutilized.

Precision medicine allows targeting of protein in acute myeloid leukemia.

CBX8 protein may lead to new treatments for breast cancer.

Protein that helps cancer cells survive during metastasis may lead to novel treatments.

ABT-414 receives designation for the treatment of diffuse intrinsic pontine glioma (DIPG).

Recent advances and updates in oncology and cancer drug development.

Top news of the day from across the health care landscape.

An award of $55 million will help launch different infrastructure needed to improve precision medicine.

Surgery combined with chemotherapy and radiation may be a good option for pancreatic cancer patients whose tumors involved blood vessels.

Chimeric antigen receptor T cell therapy targets advanced forms of leukemia and lymphoma.

Some tumors can remain undetected from current cancer treatments.